{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T15:09:01Z","timestamp":1793286541493,"version":"4.5.0"},"reference-count":140,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T00:00:00Z","timestamp":1660867200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Since December 2019, a new coronavirus, called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread around the world, causing the coronavirus 2019 (COVID-19) pandemic. From the beginning, SARS-CoV-2 has put a strain on the health system. In fact, many patients have had severe forms of the disease with the need for hospitalization due to respiratory failure. To contain the pandemic, the most widely used approach has been lockdowns. Social restrictions have been reduced thanks to the development of vaccines and targeted therapies. However, fatal events still occur among people at high risk of serious infection, such as patients with concomitant diabetes. Different mechanisms have been proposed to explain the poor prognosis of patients with diabetes and COVID-19, but the specific cause is unclear. It is now known that insulin resistance, inflammation, and cytokine storm are involved. Moreover, SARS-CoV-2 uses the angiotensin-converting enzyme 2 receptors to enter cells. This receptor is expressed on pancreatic beta cells and, during infection, it appears that receptor involvement may induce hyperglycemia in patients with or without diabetes. In this study, we discuss the mechanisms underlying the poor prognosis in people with COVID-19 and diabetes and what may improve the outcome in these patients.<\/jats:p>","DOI":"10.3389\/fendo.2022.974540","type":"journal-article","created":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T07:44:22Z","timestamp":1660895062000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["COVID-19 and diabetes\u2014Two giants colliding: From pathophysiology to management"],"prefix":"10.3389","volume":"13","author":[{"given":"Maria Chiara","family":"Pelle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Zaffina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Provenzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovenale","family":"Moirano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Arturi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.18632\/aging.103000","article-title":"Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis","volume":"12","author":"Wang","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"B3","unstructured":"World health organization"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1136\/jech-2020-214401","article-title":"The COVID-19 pandemic and health inequalities","volume":"74","author":"Bambra","year":"2020","journal-title":"J Epidemiol Community Health"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1525\/maq.2003.17.4.423","article-title":"Syndemics and public health: reconceptualizing disease in bio-social context","volume":"17","author":"Singer","year":"2003","journal-title":"Med Anthropol Q"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(20)30271-0","article-title":"Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study","volume":"8","author":"Holman","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108072","article-title":"Global and regional estimates and projections of diabetes-related health expenditure: Results from the international diabetes federation diabetes atlas, 9th edition","volume":"162","author":"Williams","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"B8","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1159\/000345107","article-title":"Diabetes and infection: is there a link?\u2013a mini-review","volume":"59","author":"Knapp","year":"2013","journal-title":"Gerontology"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.6775","article-title":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the new York city area","volume":"323","author":"Richardson","year":"2020","journal-title":"JAMA"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.4683","article-title":"Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy","volume":"323","author":"Onder","year":"2020","journal-title":"JAMA"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72: 314 cases from the Chinese center for disease control and prevention","volume":"323","author":"Wu","year":"2020","journal-title":"JAMA"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-020-05180-x","article-title":"Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study","volume":"63","author":"Cariou","year":"2020","journal-title":"Diabetologia"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2021.100105","article-title":"Severe COVID-19 in people with type 1 and type 2 diabetes in Sweden: A nationwide retrospective cohort study","volume":"4","author":"Rawshani","year":"2021","journal-title":"Lancet Reg Health Eur"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14099","article-title":"Newly diagnosed diabetes is associated with a higher risk of mortality than known diabetes in hospitalized patients with COVID-19","volume":"22","author":"Li","year":"2020","journal-title":"Diabetes Obes Metab"},{"key":"B16","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/S2213-8587(20)30405-8","article-title":"Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland","volume":"9","author":"McGurnaghan","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(20)30272-2","article-title":"Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study","volume":"8","author":"Barron","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-020-01586-6","article-title":"Is diabetes mellitus a risk factor for COronaVIrus disease 19 (COVID-19)","volume":"57","author":"Pugliese","year":"2020","journal-title":"Acta Diabetol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2006.01861.x","article-title":"Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS","volume":"23","author":"Yang","year":"2006","journal-title":"Diabetes Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1177\/1932296820924469","article-title":"Glycemic characteristics and clinical outcomes of COVID-19 patients hospitalized in the united states","volume":"14","author":"Bode","year":"2020","journal-title":"J Diabetes Sci Technol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14086","article-title":"The clinical characteristics and outcomes of patients with diabetes and secondary hyperglycaemia with coronavirus disease 2019: A single-centre, retrospective, observational study in wuhan","volume":"22","author":"Zhang","year":"2020","journal-title":"Diabetes Obes Metab"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2003-4-8-225","article-title":"Angiotensin-i-converting enzyme and its relatives","volume":"4","author":"Riordan","year":"2003","journal-title":"Genome Biol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108132","article-title":"COVID-19, diabetes mellitus and ACE2: The conundrum","volume":"162","author":"Pal","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-020-0353-9","article-title":"Endocrine and metabolic link to coronavirus infection","volume":"16","author":"Bornstein","year":"2020","journal-title":"Nat Rev Endocrinol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-020-0279-4","article-title":"Controversies of renin-angiotensin system inhibition during the COVID-19 pandemic","volume":"16","author":"South","year":"2020","journal-title":"Nat Rev Nephrol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00127-20","article-title":"Receptor recognition by the novel coronavirus from wuhan: an analysis based on decade-long structural studies of SARS coronavirus","volume":"94","author":"Wan","year":"2020","journal-title":"J Virol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18030563","article-title":"Characterization of ACE and ACE2 expression within different organs of the NOD mouse","volume":"18","author":"Roca-Ho","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B28","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1900\/RDS.2012.9.23","article-title":"The diabetic lung\u2013a new target organ","volume":"9","author":"Pitocco","year":"2012","journal-title":"Rev Diabetes Stud"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-019-09516-w","article-title":"Diabetic lung disease: fact or fiction","volume":"20","author":"Kolahian","year":"2019","journal-title":"Rev Endocr Metab Disord"},{"key":"B30","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1146\/annurev.immunol.15.1.675","article-title":"Human chemokines: an update","volume":"15","author":"Baggiolini","year":"1997","journal-title":"Annu Rev Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"493","DOI":"10.2174\/1389450033490966","article-title":"Activated T lymphocytes in type 2 diabetes: implications from in vitro studies","volume":"4","author":"Stentz","year":"2003","journal-title":"Curr Drug Targets"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/6494795","article-title":"Role of T lymphocytes in type 2 diabetes and diabetes-associated inflammation","volume":"2017","author":"Xia","year":"2017","journal-title":"J Diabetes Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2020.05.008","article-title":"Prognostic factors in patients with diabetes hospitalized for COVID-19: Findings from the CORONADO study and other recent reports","volume":"46","author":"Scheen","year":"2020","journal-title":"Diabetes Metab"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2020.104370","article-title":"Prognostic value of interleukin-6, c-reactive protein, and procalcitonin in patients with COVID-19","volume":"127","author":"Liu","year":"2020","journal-title":"J Clin Virol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/s13256-020-02595-3","article-title":"Late-onset myocardial infarction and autoimmune haemolytic anaemia in a COVID-19 patient without respiratory symptoms, concomitant with a paradoxical increase in inflammatory markers: a case report","volume":"14","author":"Pelle","year":"2020","journal-title":"J Med Case Rep"},{"key":"B36","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1055\/s-0040-1710018","article-title":"COVID-19-Related severe hypercoagulability in patients admitted to intensive care unit for acute respiratory failure","volume":"120","author":"Spiezia","year":"2020","journal-title":"Thromb Haemost"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16791","article-title":"More on COVID-19 coagulopathy in Caucasian patients","volume":"189","author":"Fogarty","year":"2020","journal-title":"Br J Haematol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3803\/EnM.2020.719","article-title":"Fasting plasma glucose level independently predicts the mortality of patients with coronavirus disease 2019 infection: A multicenter, retrospective cohort study","volume":"35","author":"Chang","year":"2020","journal-title":"Endocrinol Metab (Seoul)"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108338","article-title":"Hyperglycemia is a strong predictor of poor prognosis in COVID-19","volume":"167","author":"Liu","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2020.07.050","article-title":"Diabetic ketoacidosis precipitated by COVID-19: A report of two cases and review of literature","volume":"14","author":"Reddy","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjms.2015.11.011","article-title":"The effect of short-term hyperglycemia on the innate immune system","volume":"351","author":"Jafar","year":"2016","journal-title":"Am J Med Sci"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108561","article-title":"High admission blood glucose independently predicts poor prognosis in COVID-19 patients: A systematic review and dose-response meta-analysis","volume":"171","author":"Lazarus","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1002\/iub.2536","article-title":"One-year mortality and consequences of COVID-19 in cancer patients: A cohort study","volume":"73","author":"Chai","year":"2021","journal-title":"IUBMB Life"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.27737","article-title":"Effect of elevated fasting blood glucose level on the 1-year mortality and sequelae in hospitalized COVID-19 patients: A bidirectional cohort study","volume":"94","author":"Chai","year":"2022","journal-title":"J Med Virol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1016\/j.cell.2020.05.006","article-title":"Host-viral infection maps reveal signatures of severe COVID-19 patients","volume":"181","author":"Bost","year":"2020","journal-title":"Cell"},{"key":"B46","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.cmet.2020.07.007","article-title":"Elevated glucose levels favor SARS-CoV-2 infection and monocyte response through a HIF-1\u03b1\/Glycolysis-Dependent axis","volume":"32","author":"Codo","year":"2020","journal-title":"Cell Metab"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108382","article-title":"Hyperglycemia without diabetes and new-onset diabetes are both associated with poorer outcomes in COVID-19","volume":"167","author":"Singh","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-S002","article-title":"American Diabetes association. 2. classification and diagnosis of diabetes: Standards of medical care in diabetes-2020","volume":"43","year":"2020","journal-title":"Diabetes Care"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3321","article-title":"Covid-19 and diabetes mellitus: unveiling the interaction of two pandemics","volume":"36","author":"Maddaloni","year":"2020","journal-title":"Diabetes Metab Res Rev"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(20)30238-2","article-title":"COVID-19 in people with diabetes: understanding the reasons for worse outcomes","volume":"8","author":"Apicella","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2018688","article-title":"New-onset diabetes in covid-19","volume":"383","author":"Rubino","year":"2020","journal-title":"N Engl J Med"},{"key":"B52","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1016\/j.cmet.2021.10.014.","article-title":"Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2","volume":"33","author":"Reiterer","year":"2021","journal-title":"Cell Metab"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.109041","article-title":"Fasting plasma glucose and glucose fluctuation are associated with COVID-19 prognosis regardless of pre-existing diabetes","volume":"180","author":"Xie","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-021-00347-1","article-title":"SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas","volume":"3","author":"M\u00fcller","year":"2021","journal-title":"Nat Metab"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-021-00407-6","article-title":"Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection","volume":"3","author":"Montefusco","year":"2021","journal-title":"Nat Metab"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)08415-9","article-title":"Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview","volume":"355","author":"Capes","year":"2000","journal-title":"Lancet"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-1318","article-title":"COVID-19, hyperglycemia, and new-onset diabetes","volume":"44","author":"Khunti","year":"2021","journal-title":"Diabetes Care"},{"key":"B58","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.53.4.989","article-title":"Improved islet morphology after blockade of the renin- angiotensin system in the ZDF rat","volume":"53","author":"Tikellis","year":"2004","journal-title":"Diabetes"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-020-02444-9","article-title":"Hypothesized mechanisms explaining poor prognosis in type 2 diabetes patients with COVID-19: a review","volume":"70","author":"Lisco","year":"2020","journal-title":"Endocrine"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108166","article-title":"Diabetic ketoacidosis precipitated by covid-19 in a patient with newly diagnosed diabetes mellitus","volume":"164","author":"Chee","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"B62","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s11906-012-0323-2","article-title":"The renin angiotensin aldosterone system and insulin resistance in humans","volume":"15","author":"Underwood","year":"2013","journal-title":"Curr Hypertens Rep"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2020.04.044","article-title":"Is diabetes mellitus associated with mortality and severity of COVID-19? a meta-analysis","volume":"14","author":"Kumar","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"B64","doi-asserted-by":"publisher","first-page":"101204","DOI":"10.1016\/j.diabet.2020.10.002","article-title":"Potential metabolic and inflammatory pathways between COVID-19 and new-onset diabetes","volume":"47","author":"Sathish","year":"2021","journal-title":"Diabetes Metab"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000122852.22604.78","article-title":"Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? the common soil hypothesis revisited","volume":"24","author":"Ceriello","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12944-015-0123-1","article-title":"The role of fatty acids in insulin resistance","volume":"14","author":"Sears","year":"2015","journal-title":"Lipids Health Dis"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-020-00339-7","article-title":"Can COVID-19 cause diabetes","volume":"3","author":"Accili","year":"2021","journal-title":"Nat Metab"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-021-02729-7","article-title":"The complex combination of COVID-19 and diabetes: pleiotropic changes in glucose metabolism","volume":"72","author":"Mahrooz","year":"2021","journal-title":"Endocrine"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2020.158849","article-title":"Cholesterol, lipoproteins, and COVID-19: Basic concepts and clinical applications","volume":"1866","author":"Ko\u010dar","year":"2021","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2020.07.015","article-title":"Declined serum high density lipoprotein cholesterol is associated with the severity of COVID-19 infection","volume":"510","author":"Hu","year":"2020","journal-title":"Clin Chim Acta"},{"key":"B71","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s12944-020-01382-9","article-title":"Low high-density lipoprotein level is correlated with the severity of COVID-19 patients: an observational study","volume":"19","author":"Wang","year":"2020","journal-title":"Lipids Health Dis"},{"key":"B72","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.cca.2021.02.011","article-title":"Lipid metabolism changes in patients with severe COVID-19","volume":"517","author":"Li","year":"2021","journal-title":"Clin Chim Acta"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2021.101092","article-title":"Dissecting lipid metabolism alterations in SARS-CoV-2","volume":"82","author":"Casari","year":"2021","journal-title":"Prog Lipid Res"},{"key":"B74","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cytogfr.2020.06.001","article-title":"SARS-CoV-2 infection: The role of cytokines in COVID-19 disease","volume":"54","author":"Costela-Ruiz","year":"2020","journal-title":"Cytokine Growth Factor Rev"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102537","article-title":"The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease","volume":"19","author":"McGonagle","year":"2020","journal-title":"Autoimmun Rev"},{"key":"B76","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1161\/01.atv.14.1.8","article-title":"Cytokines decrease apolipoprotein accumulation in medium from hep G2 cells","volume":"14","author":"Ettinger","year":"1994","journal-title":"Arterioscler Thromb"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009127","article-title":"Lipid droplets fuel SARS-CoV-2 replication and production of inflammatory mediators","volume":"16","author":"Dias","year":"2020","journal-title":"PloS Pathog"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.06.006","article-title":"COVID-19 and the liver","volume":"73","author":"Jothimani","year":"2020","journal-title":"J Hepatol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.28.12.2901","article-title":"Type 2 diabetes as a \"coronary heart disease equivalent\": an 18-year prospective population-based study in Finnish subjects","volume":"28","author":"Juutilainen","year":"2005","journal-title":"Diabetes Care"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-0598","article-title":"Clinical characteristics and risk factors for mortality of COVID-19 patients with diabetes in wuhan, China: A two-center, retrospective study","volume":"43","author":"Shi","year":"2020","journal-title":"Diabetes Care"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-0660","article-title":"Clinical characteristics and outcomes of patients with diabetes and COVID-19 in association with glucose-lowering medication","volume":"43","author":"Chen","year":"2020","journal-title":"Diabetes Care"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-020-01626-9","article-title":"Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China","volume":"109","author":"Li","year":"2020","journal-title":"Clin Res Cardiol"},{"key":"B83","article-title":"Prevalence of underlying diseases in hospitalized patients with COVID-19: a systematic review and meta-analysis","volume":"8","author":"Emami","year":"2020","journal-title":"Arch Acad Emerg Med"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2007621","article-title":"Cardiovascular disease, drug therapy, and mortality in covid-19","volume":"382","author":"Mehra","year":"2020","journal-title":"N Engl J Med"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108454","article-title":"Clinical features of patients with type 2 diabetes with and without covid-19: A case control study (CoViDiab I)","volume":"169","author":"Maddaloni","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"B86","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s12933-020-01140-2","article-title":"Cardiometabolic multimorbidity is associated with a worse covid-19 prognosis than individual cardiometabolic risk factors: a multicentre retrospective study (CoViDiab II)","volume":"19","author":"Maddaloni","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.cmet.2020.04.021","article-title":"Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes","volume":"31","author":"Zhu","year":"2020","journal-title":"Cell Metab"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1177\/20420188211054686","article-title":"The importance of physical activity in management of type 2 diabetes and COVID-19","volume":"12","author":"Seidu","year":"2021","journal-title":"Ther Adv Endocrinol Metab"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2021-325353","article-title":"Diet quality and risk and severity of COVID-19: a prospective cohort study","volume":"70","author":"Merino","year":"2021","journal-title":"Gut"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.05.047","article-title":"Healthful and unhealthful plant-based diets and the risk of coronary heart disease in U.S","volume":"70","author":"Satija","year":"2017","journal-title":"Adults J Am Coll Cardiol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2165\/00024677-200302020-00003","article-title":"Diabetic ketoacidosis: risk factors and management strategies","volume":"2","author":"Umpierrez","year":"2003","journal-title":"Treat Endocrinol"},{"key":"B92","unstructured":"The Chinese diabetes society. expert recommendation on blood glucose management strategies for diabetes mellitus with new coronavirus pneumonia"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1111\/dme.14509","article-title":"An overview of COVID-19 in people with diabetes: Pathophysiology and considerations in the inpatient setting","volume":"38","author":"Fleming","year":"2021","journal-title":"Diabetes Med"},{"key":"B94","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41574-020-00435-4","article-title":"COVID-19 and diabetes mellitus: from pathophysiology to clinical management","volume":"17","author":"Lim","year":"2021","journal-title":"Nat Rev Endocrinol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.784459","article-title":"Diabetes, metformin and the clinical course of covid-19: Outcomes, mechanisms and suggestions on the therapeutic use of metformin","volume":"13","author":"Bailey","year":"2022","journal-title":"Front Pharmacol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108167","article-title":"COVID-19 and diabetes: Is metformin a friend or foe","volume":"164","author":"Ursini","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1002\/edm2.301","article-title":"Inpatient use of metformin and acarbose is associated with reduced mortality of COVID-19 patients with type 2 diabetes mellitus","volume":"5","author":"Li","year":"2022","journal-title":"Endocrinol Diabetes Metab"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(20)30152-2","article-title":"Practical recommendations for the management of diabetes in patients with COVID-19","volume":"8","author":"Bornstein","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2020.12.026","article-title":"Non-insulin anti-diabetic agents in patients with type 2 diabetes and COVID-19: A critical appraisal of literature","volume":"15","author":"Singh","year":"2021","journal-title":"Diabetes Metab Syndr"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-1340","article-title":"Impact of comorbidities and glycemia at admission and dipeptidyl peptidase 4 inhibitors in patients with type 2 diabetes with COVID-19: A case series from an academic hospital in Lombardy, Italy","volume":"43","author":"Mirani","year":"2020","journal-title":"Diabetes Care"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108125","article-title":"COVID-19 and diabetes: Can DPP4 inhibition play a role","volume":"162","author":"Iacobellis","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3330","article-title":"DPP4 inhibition: Preventing SARS-CoV-2 infection and\/or progression of COVID-19","volume":"36","author":"Strollo","year":"2020","journal-title":"Diabetes Metab Res Rev"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1007\/s00005-020-00602-5","article-title":"DPP4 inhibitors and COVID-19-Holy grail or another dead end","volume":"69","author":"Krejner-Bienias","year":"2021","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.01161","article-title":"DPP4 and ACE2 in diabetes and COVID-19: Therapeutic targets for cardiovascular complications","volume":"11","author":"Valencia","year":"2020","journal-title":"Front Pharmacol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.2478\/acph-2021-0013","article-title":"Sitagliptin: a potential drug for the treatment of COVID-19","volume":"71","author":"Bardaweel","year":"2021","journal-title":"Acta Pharm"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22147605","article-title":"Therapy of type 2 diabetes in patients with SARS-CoV-2 infection","volume":"22","author":"Bielka","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1080\/14787210.2021.1964955","article-title":"Anti-inflammatory effects of GLP-1 in patients with COVID-19","volume":"20","author":"Sazgarnejad","year":"2022","journal-title":"Expert Rev Anti Infect Ther"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1111\/bph.12159","article-title":"ACE2, angiotensin-(1-7) and mas receptor axis in inflammation and fibrosis","volume":"169","author":"Sim\u00f5es e Silva","year":"2013","journal-title":"Br J Pharmacol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.2337\/db21-0385","article-title":"Diabetes, drug treatment, and mortality in COVID-19: A multinational retrospective cohort study","volume":"70","author":"Nyland","year":"2021","journal-title":"Diabetes"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.109031","article-title":"Pre-admission glucagon-like peptide-1 receptor agonist (GLP-1RA) and mortality from coronavirus disease 2019 (Covid-19): A systematic review, meta-analysis, and meta-regression","volume":"179","author":"Hariyanto","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108146","article-title":"Should anti-diabetic medications be reconsidered amid COVID-19 pandemic","volume":"163","author":"Pal","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2020.04.019","article-title":"Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic","volume":"14","author":"Cure","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.13326","article-title":"Dissecting the interaction between COVID-19 and diabetes mellitus","volume":"11","author":"Chee","year":"2020","journal-title":"J Diabetes Investig"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-0723","article-title":"Outcomes in patients with hyperglycemia affected by COVID-19: Can we do more on glycemic control","volume":"43","author":"Sardu","year":"2020","journal-title":"Diabetes Care"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnaa011","article-title":"Coronavirus infections and type 2 diabetes-shared pathways with therapeutic implications","volume":"41","author":"Drucker","year":"2020","journal-title":"Endocr Rev"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.3390\/medicina57040341","article-title":"Characteristics, management, and outcomes of elderly patients with diabetes in a covid-19 unit: Lessons learned from a pilot study","volume":"57","author":"Ricchio","year":"2021","journal-title":"Medicina (Kaunas)"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.704666","article-title":"Metformin in patients with COVID-19: A systematic review and meta-analysis","volume":"8","author":"Li","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201712-2570OC","article-title":"AMP-activated protein kinase phosphorylation of angiotensin-converting enzyme 2 in endothelium mitigates pulmonary hypertension","volume":"198","author":"Zhang","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v23.i28.5196","article-title":"Sex-dependent difference in the effect of metformin on colorectal cancer-specific mortality of diabetic colorectal cancer patients","volume":"23","author":"Park","year":"2017","journal-title":"World J Gastroenterol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-7568(20)30033-7","article-title":"Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis","volume":"2","author":"Bramante","year":"2021","journal-title":"Lancet Healthy Longev"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2020.03.002","article-title":"Clinical considerations for patients with diabetes in times of COVID-19 epidemic","volume":"14","author":"Gupta","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01387-19","article-title":"Molecular basis of binding between middle East respiratory syndrome coronavirus and CD26 from seven bat species","volume":"94","author":"Yuan","year":"2020","journal-title":"J Virol"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1038\/nature12005","article-title":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC","volume":"495","author":"Raj","year":"2013","journal-title":"Nature"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14097","article-title":"Exposure to dipeptidyl-peptidase-4 inhibitors and COVID-19 among people with type 2 diabetes: A case-control study","volume":"22","author":"Fadini","year":"2020","journal-title":"Diabetes Obes Metab"},{"key":"B125","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.2337\/dc20-1521","article-title":"Sitagliptin treatment at the time of hospitalization was associated with reduced mortality in patients with type 2 diabetes and COVID-19: A multicenter, case-control, retrospective, observational study","volume":"43","author":"Solerte","year":"2020","journal-title":"Diabetes Care"},{"key":"B126","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.virol.2014.10.006","article-title":"Identification of residues on human receptor DPP4 critical for MERS-CoV binding and entry","author":"Song","year":"2014","journal-title":"Virology"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1016\/j.therap.2020.12.015","article-title":"A meta-analysis on the preadmission use of DPP-4 inhibitors and risk of a fatal or severe course of illness in patients with COVID-19","volume":"76","author":"Kow","year":"2021","journal-title":"Therapie"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-021-01170-3","article-title":"Use of novel antidiabetic agents in patients with type 2 diabetes and COVID-19: A critical review","volume":"12","author":"Popovic","year":"2021","journal-title":"Diabetes Ther"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2019-00139","article-title":"SGLT2 inhibitors increase the risk of diabetic ketoacidosis developing in the community and during hospital admission","volume":"104","author":"Hamblin","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(21)00180-7","article-title":"Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"9","author":"Kosiborod","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-S002","article-title":"2. classification and diagnosis of diabetes: Standards of medical care in diabetes-2021","volume":"44","year":"2021","journal-title":"Diabetes Care"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1007\/s00508-020-01672-3","article-title":"Diabetes and COVID-19 : Disease-Management-People","volume":"132","author":"Peric","year":"2020","journal-title":"Wien Klin Wochenschr"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1007\/s00508-019-1447-z","article-title":"Diabetesmanagement im krankenhaus (Update 2019) [Hospital diabetes management (Update 2019)]","volume":"131","author":"Mader","year":"2019","journal-title":"Wien Klin Wochenschr"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2022.102406","article-title":"Antibody response following SARS-CoV-2 vaccination among patients with type 2 diabetes mellitus: A systematic review","volume":"16","author":"Soetedjo","year":"2022","journal-title":"Diabetes Metab Syndr"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2020.12.035","article-title":"Impaired anti-SARS-CoV-2 antibody response in non-severe COVID-19 patients with diabetes mellitus: A preliminary report","volume":"15","author":"Pal","year":"2021","journal-title":"Diabetes Metab Syndr"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-020-05284-4","article-title":"Antibody response to multiple antigens of SARS-CoV-2 in patients with diabetes: an observational cohort study","volume":"63","author":"Lampasona","year":"2020","journal-title":"Diabetologia"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14547","article-title":"Does poor glycaemic control affect the immunogenicity of the COVID-19 vaccination in patients with type 2 diabetes: The CAVEAT study","volume":"24","author":"Marfella","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14643","article-title":"Humoral immune response to COVID-19 vaccination in diabetes is age-dependent but independent of type of diabetes and glycaemic control: The prospective COVAC-DM cohort study","volume":"24","author":"Sourij","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21093377","article-title":"SARS-CoV-2 inflammatory syndrome. clinical features and rationale for immunological treatment","volume":"21","author":"Prete","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30116-8","article-title":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection","volume":"8","author":"Fang","year":"2020","journal-title":"Lancet Respir Med"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.974540\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T07:44:29Z","timestamp":1660895069000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.974540\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,19]]},"references-count":140,"alternative-id":["10.3389\/fendo.2022.974540"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.974540","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,19]]},"article-number":"974540"}}